title: [Expression of cyclin A in adult patients with acute leukemia].
abstract: OBJECTIVE
  To investigate the clinical significance of cyclin A expression in adult patients with acute leukemia (AL).
  
  
  METHODS
  4 ml bone marrow was extracted from 100 AL patients and 10 normal controls to isolate the mononuclear cells (MNCs). The cyclin A mRNA levels in these MNCs were measured by RT-PCR. The cyclin A protein level and cell cycle in 75 randomly selected AL patients and 10 normal controls were examined by flow cytometric analysis.
  
  
  RESULTS
  (1) The distribution of cyclin A protein was normal in cell cycle in AL patients. The positive rates of cyclin A protein and mRNA were 66.7% and 59%, significantly higher than those in the normal controls (0 and 1.4% respectively, both P < 0.01). The median expression levels of cyclin A protein and mRNA of cyclin A in AL patients were 18.5% and 0.539 +/- 0.490 respectively, significantly higher than those in the normal controls (both P < 0.01). Sequence analysis showed a complete consistency between the positive segment of cyclin A and the objective gene in GeneBank. (2) The levels of cyclin A protein and mRNA were positively correlated with the cumulative percentages of cells in S and G(2)/M phases (P < 0.01). (3) The expression level of cyclin A protein in the recurrent acute lymphoblastic leukemia (ALL) group was 15.4%, significantly lower than those of de novo group (29.5%, t = 14.418, P = 0.022). (4) The complete remission (CR) rates in the AL patients with high expression levels of cyclin A protein and mRNA group were 87.9% and 85.7% respectively, significantly higher than those in the AL patients with low expression levels (38.2% and 53.5% respectively, both P < 0.01). Multivariate regression analysis showed that cyclin A was one of the influencing factors of CR rate of AL patients (P < 0.05).
  
  
  CONCLUSIONS
  Cyclin A expression contributes to the high proliferative activity in leukemia cells. The abnormal expression of cyclin A might be a prognostic marker of CR rate in AL patients.
authors.affiliation: Department of Hematology, Second Hospital, Hebei Medical University, Shijiazhuang 050000, China.
authors.forename: Jie
authors.initials: J
authors.lastname: Ma
authors.forename: Shi-rong
authors.initials: SR
authors.lastname: Xu
authors.forename: Jin-song
authors.initials: JS
authors.lastname: Jia
authors.forename: Wei-dong
authors.initials: WD
authors.lastname: Ma
authors.forename: Ying
authors.initials: Y
authors.lastname: Wang
authors.forename: Xiao-jun
authors.initials: XJ
authors.lastname: Liu
authors.forename: Yong-rong
authors.initials: YR
authors.lastname: Lai
authors.forename: Yu-ying
authors.initials: YY
authors.lastname: Lu
mesh_terms: D000208:Acute Disease; D000328:Adult; D019925:Cyclin A / Q000032:analysis* / Q000235:genetics; D005260:Female; D005434:Flow Cytometry; D006801:Humans; D007938:Leukemia / Q000378:metabolism*; D008297:Male; D012333:RNA, Messenger / Q000032:analysis; D012008:Recurrence; D020133:Reverse Transcriptase Polymerase Chain Reaction
chemical_list: D019925:Cyclin A; D012333:RNA, Messenger